Global Oncology/Cancer Drugs Market Insights and Forecast to 2027

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.

Market Analysis and Insights: Global Oncology/Cancer Drugs Market
The global Oncology/Cancer Drugs market is valued at US$ 92220 million in 2019. The market size will reach US$ 124310 million by the end of 2026, growing at a CAGR of 4.3% during 2021-2026.

Global Oncology/Cancer Drugs Scope and Market Size
Oncology/Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology/Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.


Segment by Type
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other


Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other


By Company
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company


By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia